ChiCTR2100046791 版本V1.5 版本创建时间2021/12/25 23:08:04 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100046791 

最近更新日期:

Date of Last Refreshed on:

2021-12-25 23:03:18 

注册时间:

Date of Registration:

2021-05-28 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

请于伦理委员会批准后才开始征募参试者,并与我们联系上传伦理批件。 机械通气患者过度镇静的定义及评估:一项多中心、前瞻性、队列研究

Public title:

Definition and evaluation of over-sedation in patients with mechanical ventilation: a multicenter, prospective, cohort study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

机械通气患者过度镇静的定义及评估:一项多中心、前瞻性、队列研究

Scientific title:

Definition and evaluation of over-sedation in patients with mechanical ventilation: a multicenter, prospective, cohort study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

马朋林 

研究负责人:

马朋林 

Applicant:

Ma Penglin 

Study leader:

Ma Penglin 

申请注册联系人电话:

Applicant telephone:

+86 13810339898

研究负责人电话:

Study leader's
telephone:

+86 13810339898

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

mapenglin1@163.com

研究负责人电子邮件:

Study leader's E-mail:

mapenglin1@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

贵州省贵阳市乌当区东风大道1号

研究负责人通讯地址:

贵州省贵阳市乌当区东风大道1号

Applicant address:

1 Dongfeng Avenue, Wudang District, Guiyang, Guizhou

Study leader's address:

1 Dongfeng Avenue, Wudang District, Guiyang, Guizhou

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

贵黔国际总医院

Applicant's institution:

Guiqian International General Hospital

研究负责人所在单位:

贵黔国际总医院

Affiliation of the Leader:

Guiqian International General Hospital

是否获伦理委员会批准:

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

贵黔国际总医院

Primary sponsor:

Guiqian International General Hospital

研究实施负责(组长)单位地址:

贵州省贵阳市乌当区东风大道1号

Primary sponsor's address:

1 Dongfeng Avenue, Wudang District, Guiyang, Guizhou

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

贵州

市(区县):

贵阳

Country:

China

Province:

Guizhou

City:

Guiyang

单位(医院):

贵黔国际总医院

具体地址:

乌当区东风大道1号

Institution
hospital:

Guiqian International General Hospital

Address:

1 Dongfeng Avenue, Wudang District

经费或物资来源:

中华国际医学交流基金会

Source(s) of funding:

Chinese International Medical Exchange Foundation

研究疾病:

机械通气  

Target disease:

Mechanical Ventilation

研究疾病代码:

Target disease code:

研究类型:

筛查

Study type:

Screening

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

通过建立一个对过度镇静的精确定义和风险评估工具,为机械通气患者实施适当的镇静。  

Objectives of Study:

Perform appropriate sedation for mechanically ventilated patients by developing a precise definition and risk assessment tool for excessive sedation.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.病例收集期间新入ICU;
2.接受机械通气、且预计机械通气时间>=48小时;
3.年龄>=18岁,且<80岁。

Inclusion criteria

1.Newly admitted to ICU during case collection;
2.Receiving mechanical ventilation, and the estimated duration of mechanical ventilation >=48 hours;
3.Aged 18 to 80 years.

排除标准:

1.GCS评分<8 (洗脱镇静药物影响);
2.接受CPR后入ICU;
3.存在神经肌肉疾病;
4.机械通气48小时内进行气管切开;
5.48小时内死亡;
6.放弃重症治疗。

Exclusion criteria:

1.GCS Score <8 (removing the effect of sedative drugs);
2.Entering ICU after receiving CPR;
3.With neuromuscular diseases;
4.Tracheotomy performed within 48 hours of mechanical ventilation;
5.Died within 48 hours;
6.Giving up treatments in ICU.

研究实施时间:

Study execute time:

From 2021-07-01 00:00:00 To 2023-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-07-01 00:00:00 To 2023-06-30 00:00:00

干预措施:

Interventions:

组别:

连续入组

样本量:

1435

Group:

Case series

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

贵州 

市(区县):

贵阳 

Country:

China

Province:

Guizhou

City:

Guiyang

单位(医院):

贵黔国际总医院 

单位级别:

三级甲等 

Institution
hospital:

Guiqian International General Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

机械通气时间

指标类型:

主要指标

Outcome:

Mechanical ventilation time

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

不良临床预后发生率

指标类型:

主要指标

Outcome:

Incidence of adverse clinical outcomes

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

本研究在各中心进行各相关因素的分析,不涉及具体分组。

Randomization Procedure (please state who generates the random number sequence and by what method):

In this study, the relevant factors were analyzed in each center and no specific grouping was involved.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

网络。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Network.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集表。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data acquisition table.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-05-28 09:12:24